|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0015133,
umls-concept:C0024299,
umls-concept:C0025815,
umls-concept:C0026259,
umls-concept:C0035020,
umls-concept:C0085405,
umls-concept:C0205269,
umls-concept:C0282460,
umls-concept:C0348016,
umls-concept:C0442027,
umls-concept:C1170010
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-4-26
|
|
pubmed:abstractText |
To evaluate the response to oral Etoposide when combined with mesna, ifosfamide, and mitoxantrone in patients with relapsed and/or refractory lymphoma. To evaluate response and its duration after administration of intravenous Etoposide, methylprednisolone, high-dose cytosine arabinoside, and cisplatin (ESHAP) as consolidation therapy after complete or partial responses (CR or PR, respectively) or after crossover therapy for progressive disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0167-6997
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
217-22
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7896540-Adolescent,
pubmed-meshheading:7896540-Adult,
pubmed-meshheading:7896540-Aged,
pubmed-meshheading:7896540-Aged, 80 and over,
pubmed-meshheading:7896540-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7896540-Cisplatin,
pubmed-meshheading:7896540-Cross-Over Studies,
pubmed-meshheading:7896540-Cytarabine,
pubmed-meshheading:7896540-Etoposide,
pubmed-meshheading:7896540-Female,
pubmed-meshheading:7896540-Humans,
pubmed-meshheading:7896540-Ifosfamide,
pubmed-meshheading:7896540-Lymphoma,
pubmed-meshheading:7896540-Male,
pubmed-meshheading:7896540-Mesna,
pubmed-meshheading:7896540-Methylprednisolone,
pubmed-meshheading:7896540-Methylprednisolone Hemisuccinate,
pubmed-meshheading:7896540-Middle Aged,
pubmed-meshheading:7896540-Mitoxantrone,
pubmed-meshheading:7896540-Prednisone,
pubmed-meshheading:7896540-Salvage Therapy
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
|
|
pubmed:affiliation |
Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
